舌下神经刺激器植入后发生过敏性接触性皮炎
一例64岁重度阻塞性睡眠呼吸暂停男性患者,在舌下神经刺激器植入约2个月后出现右侧颈部切口局部红斑、肿胀和脓性分泌物,装置外露后取出。左侧再植入后第10天颈部与胸部切口再次出现肿胀、红斑和脓性分泌物,再次取出。伤口培养阴性,斑贴试验显示对异佛尔酮二异氰酸酯1.0%凡士林制剂呈强阳性反应,制造商确认装置聚氨酯组件含异氰酸酯。
要点
- 舌下神经刺激器植入后非感染性装置反应可表现为切口红肿、脓性分泌物和装置外露。
- 斑贴试验对异佛尔酮二异氰酸酯1.0%凡士林制剂呈强阳性,提示异氰酸酯过敏。
- 装置相关反应发生在术后伤口感染窗口之外时,应考虑非感染性原因。
核心结论
- 异氰酸酯是用于生产聚氨酯的低分子量化合物,聚氨酯常见于医疗器械。
- 关于医疗器械异氰酸酯过敏的文献有限,这可能是首例舌下神经刺激器装置确认病例。
- 本病例报告强调装置反应的非感染性原因的重要性,尤其是发生在术后伤口感染窗口之外时。
- 异氰酸酯及其他组分的斑贴试验可告知患者和临床医生装置植入失败的原因,并对未来植入装置有启示。
研究设计与样本
- 病例报告,患者就诊于四级学术医疗中心。
- 患者接受了序贯双侧舌下神经刺激器植入及后续取出。
- 主要结局为症状监测和过敏斑贴试验的结果。
主要发现
- 64岁男性重度阻塞性睡眠呼吸暂停患者,呼吸暂停低通气指数为54事件/小时,接受舌下神经刺激器植入。
- 术后2个月恢复顺利,直至报告右侧颈部切口局部红斑、肿胀和脓性分泌物。
- 术后约3个月发现颈部舌下神经刺激器装置外露,促使装置取出。
- 右侧取出后3个月行左侧颈部和胸部舌下神经刺激器再植入,术后第10天颈部和胸部切口出现肿胀、红斑和脓性分泌物,再次取出装置时胸部和颈部见无臭脓液。
- 伤口培养感染阴性,斑贴试验显示对异佛尔酮二异氰酸酯1.0%凡士林制剂呈强阳性反应,制造商确认装置聚氨酯组件含异氰酸酯。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Allergic contact reactions to medical implants are underrecognized and incompletely understood, particularly in hypoglossal nerve stimulation (HGNS), an increasingly popular and effective alternative to positive airway pressure therapy for patients with obstructive sleep apnea (OSA). OBJECTIVE: To document a rare case of allergic contact reaction in a patient following implantation of an HGNS device for OSA. DESIGN, SETTING, AND PARTICIPANT: In this case report, the patient presented to a quaternary care academic medical center with localized erythema, swelling, and pustular drainage at the right neck incision site approximately 2 months following HGNS device implantation. EXPOSURE: This patient underwent serial, bilateral HGNS device implantation and subsequent explantation. MAIN OUTCOME AND MEASURE: The main outcomes were the findings from symptom monitoring and allergy patch testing. RESULTS: A 64-year-old male patient with severe OSA (Apnea-Hypopnea Index, 54 events/h) underwent implantation of an HGNS device. His recovery was uneventful for 2 months until he reported localized erythema, swelling, and pustular drainage at the right neck incision site. HGNS device extrusion at the neck was noted approximately 3 months postoperatively, prompting device explantation. The patient underwent subsequent HGNS reimplantation in the left neck and chest 3 months after right-sided explantation. At postoperative day 10, swelling, erythema, and purulence were noted from neck and chest incisions. The device was re-explanted with odorless purulence noted in the chest and neck. The wound cultures were negative for infection, and at this time, the patient underwent allergy patch testing, which demonstrated a strong positive reaction to isophorone diisocyanate. Patch testing confirmed an allergy to isocyanates, evidenced by a strong positive reaction to isophorone diisocyanate, 1.0%, in petrolatum. This finding was further validated by the manufacturer, which confirmed isocyanates were used in the polyurethane components of the HGNS device. CONCLUSIONS AND RELEVANCE: Isocyanates are low-molecular weight compounds used in the production of polyurethanes, which are commonly found in medical devices. HGNS is a widely available implantable medical device for treatment of patients with OSA. The literature regarding isocyanate allergies with medical implants is limited, and this may be the first confirmed case with an HGNS device. This case report highlights the importance of noninfectious causes of device reactions, especially when occurring outside of the postoperative wound infection window. Patch testing for isocyanate and other components can inform both patient and clinician regarding the cause of device implantation failure and have implications for future implantable devices.
引用
- Tangutur A, Brown KK, Dedhia RC, et al. Allergic Contact Dermatitis Following Hypoglossal Nerve Stimulator Implant. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40014338. doi:10.1001/jamaoto.2024.5446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。